Systemic sclerosis (scleroderma)
Systemic sclerosis (or scleroderma) is long-term and causes thick, hard skin – possibly affecting your organs. Learn the symptoms, causes and treatment.
Systemic sclerosis - Understanding how immune cells become unregulated in systemic sclerosis
Learn about our research which aims to understand why some people with systemic sclerosis are unable to regulate immune cells responsible for inflammation.
Early Diagnosis of Systemic Sclerosis in the General Rheumatology Clinic
The aim of this project is to develop an artificial intelligence (AI) system that helps rheumatologists to diagnose systemic sclerosis (also called ‘scleroderma’) as early as possible.
Scleroderma - Developing a treatment for calcinosis in systemic sclerosis
Calcinosis can sometimes occur in systemic sclerosis. Learn more about our research into developing a treatment for calcinosis that can be applied to the skin.
Scleroderma - Mycophenolate in limited cutaneous systemic sclerosis - external pilot
Learn about our research at University College London which investigates mycophenolate in limited cutaneous systemic sclerosis as part of an external pilot.
Scleroderma - Developing a smartphone app to better assess healing of finger ulcers in systemic sclerosis
Learn about our research into the development of a new app to help diagnose, assess, monitor and heal finger ulcers in patients with systemic sclerosis.
New guidelines for systemic sclerosis and Behçets
In this article we delve into two new BSR guidelines to learn about the overarching management principles, as well as the importance of psychological care.
Systemic sclerosis - Using artificial intelligence to monitor the progression
Read more about using artificial intelligence to monitor the progression of scleroderma and psoriatic arthritis.
Scleroderma - Investigating which cells cause thickening of tissues in systemic sclerosis
Learn about our research into scleroderma, which aims to identify which type of fibroblasts lead to thickening connective tissues and how this occurs.
Scleroderma - Can immune suppressant drugs help to prevent worsening of systemic sclerosis?
Learn about our research investigating whether the immune suppressant drug mycophenolate mofetil (MMF) can help to treat a subgroup of people with scleroderma.
Fighting for a scleroderma free world: Nicola’s story.
Advocate Nicola shares why she’s fighting for change to make sure that treatment for scleroderma (or systemic sclerosis) isn’t a postcode lottery.